With increased awareness of rare diseases, the rare disease treatment market has garnered significant investment in recent years. Even though individual rare diseases might impact only a small fraction of the population they collectively form a public health priority. The rate of prevalence of rare diseases has increased from 3.5%–5.9% affecting about 260–440 million people […]
